Strategic SDVOSB Applied Biologics recently earned Service-Disabled Veteran-Owned Small Business certification, signaling potential access to SDVOSB-specific procurement programs and set-aside opportunities that can be pursued with government and large healthcare organizations prioritizing veteran-owned suppliers.

Gene Therapy Pipeline With programs like APPB-429 for diabetic peripheral neuropathy and BIOxHEAL featuring a Phase 3 chronic wounds program and osteoarthritis gene therapy research, there is clear cross-sell potential for specialized delivery devices, containment, and manufacturing collaboration partnerships.

Proprietary Platform The ECM Preservation Technology platform underpins XWRAP, suggesting opportunities to offer compatible biomanufacturing services, materials, and contract manufacturing capabilities to support scale, quality systems, and regulatory readiness for similar biologic products.

Clinical Collaboration Ongoing and expanding partnerships with healthcare networks such as Providence Health & Services indicate a track record of collaboration with large integrated delivery systems, presenting a pathway for enterprise procurement of medical technologies and research tools.

Global Launch Readiness Active participation in major industry forums (SAWC) and a multi-channel tech stack (Cloud, Salesforce, marketing and publishing tools) suggest readiness to scale awareness, engage surgeons and clinicians, and accelerate adoption through targeted field-based outreach and demonstrations.